Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.

Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.

Diğer sürümleri göster (1)

BACKGROUND: Zidovudine (AZT) monotherapy was the first antiretroviral drug to be tested widely. Subsequent trials in asymptomatic or early symptomatic HIV infection indicated short-term delays in disease progression with AZT, but not improved survival. OBJECTIVES: To assess the effects of immediate...

Detaylı Bibliyografya
Asıl Yazarlar:	Darbyshire, J, Foulkes, M, Peto, R, Duncan, W, Babiker, A, Collins, R, Hughes, M, Peto, T, Walker, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2000

Benzer Materyaller

Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.
Yazar:: Darbyshire, J, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
Yazar:: Darbyshire, J, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults
Yazar:: Darbyshire, J, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
Yazar:: Darbyshire, J, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Immediate versus deferred zidovudine.
Yazar:: Peto, R, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee.
Yazar:: Seligmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

Long-term follow-up of randomized trials of immediate versus deferred zidovudine in symptom-free HIV infection. Joint Concorde and Opal Coordinating Committee.
Yazar:: Aboulker, J, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Use of zidovudine.
Yazar:: Peto, T
Baskı/Yayın Bilgisi: (1989)

The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes.
Yazar:: Sim, S.M., ve diğerleri
Baskı/Yayın Bilgisi: (1991)

A critical analysis of recent data on zidovudine therapy: use in asymptomatic HIV infection and early HIV disease, dosing and resistance issues.
Yazar:: Peto, T
Baskı/Yayın Bilgisi: (1990)

Zidovudine (AZT) and hepatic lipid accumulation: implication of inflammation, oxidative and endoplasmic reticulum stress mediators.
Yazar:: Atrayee Banerjee, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Determination of the melting temperature, heat of fusion, and purity analysis of different samples of zidovudine (AZT) using DSC
Yazar:: Adriano Antunes Souza Araújo, ve diğerleri
Baskı/Yayın Bilgisi: (2010-03-01)

First line treatment of acute and chronic ATLL with zidovudine (AZT) and interferon alpha (IFN-α): haematological and molecular responses
Yazar:: Fields Paul, ve diğerleri
Baskı/Yayın Bilgisi: (2011-06-01)

Influência da geometria da plataforma na determinação de chumbo em zidovudina (AZT) por ET AAS Influence of the platform geometry on lead determination in zidovudine (AZT) by ET AAS
Yazar:: Fátima R. Moreira, ve diğerleri
Baskı/Yayın Bilgisi: (2002-05-01)

Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.
Yazar:: Jessica H Brehm, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

AZT
Yazar:: Carlos Alberto Morais de Sá, ve diğerleri
Baskı/Yayın Bilgisi: (1998-12-01)

Management of COVID-19-positive asymptomatic and mildly symptomatic children
Yazar:: G V Basavaraja, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Issues in the design and analysis of therapeutic trials in human immunodeficiency virus infection
Yazar:: Babiker, A, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Markers of HIV infection in the Concorde trial. Concorde Co-ordinating Committee.
Yazar:: Walker, A, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
Yazar:: Munderi, P, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Age as a determinant of survival in HIV infection.
Yazar:: Babiker, A, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

AZT as a telomerase inhibitor
Yazar:: Daniel E Gomez, ve diğerleri
Baskı/Yayın Bilgisi: (2012-09-01)

Conformational Study of New AZT Derivatives
Yazar:: M. T. Baumgartner, ve diğerleri
Baskı/Yayın Bilgisi: (2000-03-01)

Psychological status of asymptomatic and mildly symptomatic patients hospitalized for COVID-19
Yazar:: Prateksha Golas, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Immediate or deferred antiretroviral therapy for central nervous system opportunistic infections?
Yazar:: Torok, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Immediate aspirin for suspected ischaemic stroke.
Yazar:: Baigent, C, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

The first, the next, and the cinematographed versions of AZT
Yazar:: Paula C. JÍMENEZ
Baskı/Yayın Bilgisi: (2014-07-01)

The first, the next, and the cinematographed versions of AZT
Yazar:: Paula C Jimenez
Baskı/Yayın Bilgisi: (2014-08-01)

Olfactory and Taste Dysfunction in Patients with Asymptomatic and Mildly Symptomatic COVID-19 in Korea
Yazar:: Jun Yeon Won, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Age and Sex Differences Among Mildly Symptomatic and Asymptomatic Patients with Omicron Infection in 2022 in Shanghai, China
Yazar:: Feng C, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
Yazar:: Gibb, D, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

An unexpected evolution of symptomatic mild middle cerebral artery (MCA) stenosis: asymptomatic occlusion
Yazar:: Malferrari Giovanni, ve diğerleri
Baskı/Yayın Bilgisi: (2011-12-01)

NEUROTOXIC EFFECTS OF AZT ON DEVELOPING AND ADULT NEUROGENESIS
Yazar:: Meryem eDemir, ve diğerleri
Baskı/Yayın Bilgisi: (2015-03-01)

Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.
Yazar:: Green, H, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Immediate versus Deferred Stenting for Patients Undergoing Primary Percutaneous Coronary Intervention
Yazar:: Ahmed Almorsy, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh
Yazar:: Tahmina Shirin, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

RNA sequence analysis of nasopharyngeal swabs from asymptomatic and mildly symptomatic patients with COVID-19
Yazar:: Miftahul Faridl, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Community Treatment Centers for Isolation of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease, South Korea
Yazar:: Won Suk Choi, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul, South Korea
Yazar:: Mi Seon Han, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

„A különszám azt bizonyítja, hogy jól dolgoztunk”
Yazar:: Balázs Sárvári, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)